#1 Clinical Trials Search in Europe

Levocarnitine

Levocarnitine, also known as L-carnitine, is a compound involved in cellular energy production. It has been the subject of several clinical trials investigating its potential benefits for various medical conditions. This article summarizes key findings from recent studies exploring the use of levocarnitine in heart failure, hypothyroidism, diabetic neuropathy, and other health issues.

Table of Contents

What is Levocarnitine?

Levocarnitine, also known as L-carnitine or Carnitor, is a naturally occurring compound found in the body. It plays a crucial role in energy production within cells[1]. Levocarnitine is considered a non-essential amino acid, which means that the body can produce it on its own. However, in certain medical conditions or situations, supplementation may be necessary[2].

Conditions Treated with Levocarnitine

Levocarnitine is used to treat various medical conditions, including:

  • Heart Failure: It may help improve cardiac function in patients with heart failure[3].
  • Hypothyroidism: It may help alleviate fatigue in patients with hypothyroidism who are receiving thyroid hormone replacement therapy[2].
  • Diabetic Peripheral Neuropathy: This is a condition where diabetes causes nerve damage, leading to pain and numbness in the extremities. Levocarnitine may help relieve pain and improve symptoms[4].
  • Carnitine Deficiency in Hemodialysis Patients: Patients undergoing kidney dialysis may benefit from levocarnitine supplementation to improve heart function[5].
  • Spinal Muscular Atrophy (SMA): It may help improve muscle strength and function in patients with this genetic disorder that affects muscle strength and movement[6].
  • Chemotherapy-induced Peripheral Neuropathy: It may help prevent nerve damage caused by certain cancer treatments[7].
  • Prematurity and Neurodevelopmental Disorders: Early supplementation in very preterm infants may help improve brain development and growth[8].

How Levocarnitine Works

Levocarnitine plays a vital role in energy production within cells. It acts as a carrier molecule, transporting long-chain fatty acids into the mitochondria, which are the powerhouses of cells. Once inside the mitochondria, these fatty acids are broken down to produce energy[1].

In addition to its role in energy production, levocarnitine may also have other beneficial effects:

  • It may help reduce oxidative stress and modulate inflammatory responses in the body[9].
  • In the heart, it may improve the efficiency of energy production, potentially benefiting patients with heart failure[3].
  • In the nervous system, it may help protect nerves from damage and support their function[4].

How Levocarnitine is Administered

Levocarnitine can be administered in various ways, depending on the condition being treated and the patient’s needs:

  • Oral Supplementation: It can be taken by mouth as a syrup or tablet. For example, in some studies, patients took 1500-2000 mg per day, divided into two or three doses[2][4].
  • Intravenous (IV) Injection: In some cases, such as for patients undergoing hemodialysis, levocarnitine may be given as an injection into a vein[3].
  • For Premature Infants: In studies involving very preterm infants, levocarnitine was given intravenously at a dose of 50 micromoles per kilogram of body weight per day[8].

The exact dosage and method of administration should always be determined by a healthcare professional based on the individual patient’s needs and condition.

Ongoing Research and Potential Benefits

Researchers are continually studying levocarnitine to understand its full potential. Some areas of ongoing research include:

  • Dry Eye in Sjögren’s Syndrome: A study is investigating whether levocarnitine can help alleviate dry eye symptoms in patients with this autoimmune disorder[10].
  • Liver Protection During Cancer Treatment: Researchers are studying whether levocarnitine can help protect the liver from damage caused by certain chemotherapy drugs used to treat leukemia[9].
  • Insulin Resistance: A study is looking at whether levocarnitine can help improve the body’s response to insulin, which could be beneficial for people with diabetes or at risk of developing it[1].

Potential Side Effects

While levocarnitine is generally considered safe, like all medications, it can cause side effects in some people. Common side effects may include:

  • Nausea
  • Vomiting
  • Stomach upset
  • Headache
  • Dizziness

In most clinical trials, the side effects of levocarnitine were mild and similar to those experienced by patients taking a placebo (a substance with no active medication)[3][2].

It’s important to note that while levocarnitine shows promise in treating various conditions, more research is needed to fully understand its effects and optimal use. Always consult with a healthcare professional before starting any new medication or supplement.

Condition Study Design Intervention Key Outcomes Measured
Heart Failure Randomized, double-blind, placebo-controlled Levocarnitine injection NYHA cardiac functional grading, 6-minute walk test, left ventricular ejection fraction
Hypothyroidism Randomized, controlled trial Oral levocarnitine supplementation Fatigue levels, lipid profiles
Diabetic Peripheral Neuropathy Randomized, controlled trial Oral levocarnitine supplementation Pain scores, neuropathic symptoms
Spinal Muscular Atrophy Randomized, placebo-controlled Oral levocarnitine with valproate Muscle strength, functional motor scales
Chemotherapy-induced Peripheral Neuropathy Randomized clinical trial Oral L-carnitine L-tartrate Vibratory threshold, neuropathy symptoms

FAQ

  • What is levocarnitine and how does it work? Levocarnitine is a naturally occurring compound that helps transport fatty acids into cells' mitochondria for energy production. It plays a crucial role in cellular metabolism and energy generation.
  • What medical conditions are being studied with levocarnitine supplementation? Clinical trials are exploring levocarnitine's potential benefits in conditions such as heart failure, hypothyroidism, diabetic peripheral neuropathy, spinal muscular atrophy, and chemotherapy-induced side effects.
  • How is levocarnitine administered in these trials? Levocarnitine is typically administered orally as tablets or syrup, or intravenously as an injection. Dosages and duration vary depending on the specific study and condition being treated.
  • Are there any known side effects of levocarnitine supplementation? While generally well-tolerated, some potential side effects may include nausea, vomiting, stomach upset, and diarrhea. However, serious side effects are rare, and safety is closely monitored in clinical trials.
  • How long do these clinical trials typically last? The duration of levocarnitine clinical trials varies widely, ranging from a few weeks to several months or even a year, depending on the specific study design and objectives.

Ongoing Clinical Trials on Levocarnitine

  • Study on the Safety and Effectiveness of PolyCore (Xylitol, L-Carnitine, Polydextrin) for Patients with End-Stage Kidney Disease Starting Peritoneal Dialysis

    Recruiting

    2 1 1
    Investigated drugs:
    Italy

  • Study on Peritoneal Ultrafiltration with PolyCore for Patients with Congestive Heart Failure Using Levocarnitine and Drug Combination

    Recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on XyloCore and Drug Combination for Patients with End-Stage Kidney Disease Undergoing Peritoneal Dialysis

    Recruiting

    3 1 1 1
    Investigated drugs:
    Denmark Germany Italy Spain Sweden

  • Study on the Safety of Glucothera Plus for Children with End-Stage Kidney Disease Undergoing Peritoneal Dialysis

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study for Adults with Very High-Risk T-Cell Acute Lymphoblastic Leukemia Using Daratumumab and a Drug Combination

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Italy

  • Study on L-Carnitine and Cobamamide for Patients with Septic Shock and Acute Kidney Injury

    Not recruiting

    3 1 1
    Investigated drugs:
    France

Glossary

  • Levocarnitine: A naturally occurring compound in the body that helps transport fatty acids into cells' mitochondria for energy production. It is also available as a dietary supplement.
  • Spinal Muscular Atrophy (SMA): A genetic disorder characterized by muscle weakness and atrophy due to the loss of motor neurons in the spinal cord and brainstem.
  • Diabetic Peripheral Neuropathy: Nerve damage that occurs in people with diabetes, often causing pain, numbness, and weakness in the hands and feet.
  • Hypothyroidism: A condition in which the thyroid gland doesn't produce enough thyroid hormone, leading to various symptoms including fatigue and weight gain.
  • Keratoconjunctivitis Sicca: Also known as dry eye syndrome, a condition where the eyes don't produce enough tears or the tears evaporate too quickly.
  • Hyperinsulinemic-euglycemic Clamp: A medical procedure used to measure insulin sensitivity and glucose metabolism in research settings.
  • Metabolic Flexibility: The ability of the body to switch between using different fuel sources (like fats and carbohydrates) for energy, depending on availability and demand.
  • Left Ventricular Ejection Fraction (LVEF): A measurement of how much blood the left ventricle pumps out with each contraction, used to assess heart function.
  • Manual Muscle Testing (MMT): A method used to evaluate muscle strength by having a patient perform specific movements against resistance.
  • Forced Vital Capacity (FVC): The total amount of air exhaled during a forced breath, used to assess lung function.

References

  1. https://clinicaltrials.gov/study/NCT02722902
  2. https://clinicaltrials.gov/study/NCT03372772
  3. https://clinicaltrials.gov/study/NCT01580553
  4. https://clinicaltrials.gov/study/NCT04145245
  5. https://clinicaltrials.gov/study/NCT05673239
  6. https://clinicaltrials.gov/study/NCT01671384
  7. https://clinicaltrials.gov/study/NCT00754767
  8. https://clinicaltrials.gov/study/NCT01783041
  9. https://clinicaltrials.gov/study/NCT05501899
  10. https://clinicaltrials.gov/study/NCT03953703